Total Payments
$2,365
2024 Payments
$98.01
Companies
37
Transactions
121
Medicare Patients
606
Medicare Billing
$150,250
Payment Breakdown by Category
Food & Beverage$2,295 (97.0%)
Education$69.99 (3.0%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,295 | 120 | 97.0% |
| Education | $69.99 | 1 | 3.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $228.53 | 13 | $0 (2023) |
| GlaxoSmithKline, LLC. | $221.23 | 13 | $0 (2024) |
| ABIOMED | $216.47 | 3 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $214.26 | 12 | $0 (2023) |
| UCB, Inc. | $183.32 | 10 | $0 (2022) |
| Genentech USA, Inc. | $140.57 | 9 | $0 (2018) |
| Alexion Pharmaceuticals, Inc. | $93.47 | 2 | $0 (2018) |
| Merck Sharp & Dohme LLC | $85.33 | 5 | $0 (2022) |
| E.R. Squibb & Sons, L.L.C. | $64.92 | 5 | $0 (2022) |
| PORTOLA PHARMACEUTICALS, INC. | $62.67 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $98.01 | 7 | GlaxoSmithKline, LLC. ($76.04) |
| 2023 | $390.85 | 11 | ABIOMED ($216.47) |
| 2022 | $409.87 | 22 | Janssen Pharmaceuticals, Inc ($60.44) |
| 2021 | $19.80 | 1 | Boehringer Ingelheim Pharmaceuticals, Inc. ($19.80) |
| 2020 | $123.01 | 6 | Zimmer Biomet Holdings, Inc. ($38.65) |
| 2019 | $282.73 | 15 | Janssen Pharmaceuticals, Inc ($70.70) |
| 2018 | $528.43 | 29 | Alexion Pharmaceuticals, Inc. ($93.47) |
| 2017 | $512.08 | 30 | Genentech USA, Inc. ($81.54) |
All Payment Transactions
121 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $1.18 | General |
| Category: HFCWO | ||||||
| 12/02/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: RESPIRATORY | ||||||
| 11/04/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $20.38 | General |
| Category: RESPIRATORY | ||||||
| 10/14/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $21.09 | General |
| Category: RESPIRATORY | ||||||
| 09/16/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $9.94 | General |
| Category: HFCWO | ||||||
| 08/28/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $10.85 | General |
| Category: HFCWO | ||||||
| 01/22/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: RESPIRATORY | ||||||
| 11/13/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $18.93 | General |
| Category: RESPIRATORY | ||||||
| 10/27/2023 | Abbott Laboratories | 2ND GEN CENTRIMAG PRIMARY CONSOLE (Device) | Food and Beverage | In-kind items and services | $24.46 | General |
| Category: Heart Failure | ||||||
| 10/05/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: RESPIRATORY | ||||||
| 09/21/2023 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 09/06/2023 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $48.94 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/03/2023 | Ultragenyx Pharmaceutical Inc. | — | Food and Beverage | In-kind items and services | $29.98 | General |
| 05/15/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $27.88 | General |
| Category: RESPIRATORY | ||||||
| 04/18/2023 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $47.73 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/04/2023 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: ANTIBIOTIC | ||||||
| 02/17/2023 | Inogen, Inc. | INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) | Food and Beverage | Cash or cash equivalent | $17.22 | General |
| Category: OXYGEN CONCENTRATOR | ||||||
| 01/31/2023 | ABIOMED | Impella (Device) | Food and Beverage | In-kind items and services | $119.80 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/16/2022 | Chiesi USA, Inc. | CUROSURF (Drug) | Food and Beverage | Cash or cash equivalent | $21.27 | General |
| Category: NEONATOLOGY | ||||||
| 12/14/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT, SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $14.37 | General |
| Category: RESPIRATORY | ||||||
| 11/30/2022 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $15.61 | General |
| Category: IMMUNOLOGY | ||||||
| 11/08/2022 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: ANTIBIOTIC | ||||||
| 10/05/2022 | Bayer HealthCare Pharmaceuticals Inc. | Adempas (Drug) | Food and Beverage | In-kind items and services | $19.51 | General |
| Category: Hematology | ||||||
| 09/29/2022 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $14.52 | General |
| 09/21/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug), SPIRIVA RESPIMAT, SPIRIVA RESPIMAT | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 70 | 146 | $57,560 | $20,670 |
| 2022 | 2 | 99 | 176 | $62,096 | $22,786 |
| 2021 | 4 | 188 | 335 | $112,201 | $43,530 |
| 2020 | 4 | 249 | 442 | $160,392 | $63,264 |
Total Patients
606
Total Services
1,099
Medicare Billing
$150,250
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 42 | 104 | $50,336 | $16,961 | 33.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 28 | 42 | $7,224 | $3,709 | 51.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 49 | 102 | $49,368 | $17,216 | 34.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 50 | 74 | $12,728 | $5,570 | 43.8% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 76 | 167 | $80,828 | $29,332 | 36.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 84 | 140 | $24,080 | $10,941 | 45.4% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 13 | 13 | $4,368 | $2,079 | 47.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 15 | 15 | $2,925 | $1,177 | 40.2% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 120 | 260 | $125,840 | $47,105 | 37.4% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 92 | 145 | $24,940 | $11,872 | 47.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 17 | 17 | $5,712 | $2,603 | 45.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 20 | 20 | $3,900 | $1,683 | 43.2% |
About Dr. Jonathan Richards, MD
Dr. Jonathan Richards, MD is a Pulmonary Disease healthcare provider based in Baton Rouge, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2008. The National Provider Identifier (NPI) number assigned to this provider is 1457511362.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jonathan Richards, MD has received a total of $2,365 in payments from pharmaceutical and medical device companies, with $98.01 received in 2024. These payments were reported across 121 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($2,295).
As a Medicare-enrolled provider, Richards has provided services to 606 Medicare beneficiaries, totaling 1,099 services with total Medicare billing of $150,250. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Critical Care Medicine
- Location Baton Rouge, LA
- Active Since 06/13/2008
- Last Updated 05/28/2021
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1457511362
Products in Payments
- XARELTO (Drug) $228.53
- Impella (Device) $216.47
- Vimpat (Drug) $135.26
- Esbriet (Biological) $125.25
- OFEV (Drug) $119.18
- ELIQUIS (Drug) $81.03
- NUCALA (Biological) $78.83
- ACTHAR (Biological) $73.03
- SOLIRIS (Drug) $69.99
- STIOLTO RESPIMAT (Drug) $64.75
- ANDEXXA (Biological) $62.67
- AREXVY (Drug) $56.31
- TRELEGY ELLIPTA (Drug) $54.95
- ZERBAXA (Drug) $50.44
- Briviact (Drug) $48.06
- TYVASO (Drug) $45.31
- ENTRESTO (Drug) $43.04
- Stratum Foot Plating System (Device) $38.65
- Adempas (Drug) $38.46
- Cresemba (Drug) $36.36
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Baton Rouge
Robert Hinkle, Md, MD
Pulmonary Disease — Payments: $32,737
Pulmonary Disease $32,737
Dr. Alexander Mulamula, M.d, M.D
Pulmonary Disease — Payments: $9,086
Pulmonary Disease $9,086
Vincent Valentine, Md, MD
Pulmonary Disease — Payments: $6,427
Pulmonary Disease $6,427
Mostafa Aboubakr, Md, MD
Pulmonary Disease — Payments: $4,838
Pulmonary Disease $4,838
Stephen Brierre, Md, MD
Pulmonary Disease — Payments: $2,385
Pulmonary Disease $2,385
Dr. Stuart Lebas, M.d, M.D
Pulmonary Disease — Payments: $1,829
Pulmonary Disease $1,829